PRAVIGARD PAC (COPACKAGED) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pravigard Pac (copackaged), and what generic alternatives are available?
Pravigard Pac (copackaged) is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in PRAVIGARD PAC (COPACKAGED) is aspirin; pravastatin sodium. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; pravastatin sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PRAVIGARD PAC (COPACKAGED)?
- What are the global sales for PRAVIGARD PAC (COPACKAGED)?
- What is Average Wholesale Price for PRAVIGARD PAC (COPACKAGED)?
Summary for PRAVIGARD PAC (COPACKAGED)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PRAVIGARD PAC (COPACKAGED) at DailyMed |
US Patents and Regulatory Information for PRAVIGARD PAC (COPACKAGED)
International Patents for PRAVIGARD PAC (COPACKAGED)
See the table below for patents covering PRAVIGARD PAC (COPACKAGED) around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 374495 | ⤷ Start Trial | |
| Austria | A256781 | ⤷ Start Trial | |
| Australia | 549988 | ⤷ Start Trial | |
| Australia | 7137681 | ⤷ Start Trial | |
| Belgium | 889150 | ⤷ Start Trial | |
| Canada | 1150170 | DERIVES DE ML-236B ET LEUR PREPARATION (ML-236B DERIVATIVES AND THEIR PREPARATION) | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
-patent-expirations.png)
